Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific Herald.
Press releases published on March 20, 2025
Military Cargo Drone Market is Forecasted to Reach US$ 7,304 Million in 2035, Says Stratview Research
GlobeNewswire
·
March 20, 2025
Detroit, March 20, 2025 (GLOBE NEWSWIRE) -- The global military cargo drone market is projected to witness a growth rate of 90.7% annually from 2024 to 2035, with an anticipated size of US$ 7,304 million by 2035, according to an analysis by Stratview …
JuicyChat.AI Addresses Rising Demand with NSFW AI Chat in 2025
GlobeNewswire
·
March 20, 2025
LOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) -- As searches for NSFW AI chat tools surged 25% in 2024, JuicyChat.AI today launched an age-verified platform offering customizable, secure interactions. The tool aims to balance creative freedom with user …
Basin Energy Limited (BSN.AX) Rock Chip Results Confirm Polymetallic Potential
ABN Newswire
·
March 20, 2025
Rock Chip Results Confirm Polymetallic Potential of Central and Southern Sweden Projects Perth, Mar 20, 2025 AEST (ABN Newswire) - Basin Energy Limited (ASX:BSN) (BSNEF:OTCMKTS) is pleased to report that it has received rock chip assay results for its …
HIKMICRO Introduces "Digital System" Concept at IWA 2025, Transforming Hunting Experience
GlobeNewswire
·
March 20, 2025
Photo Courtesy of HIKMICRO NUREMBERG, Germany, March 20, 2025 (GLOBE NEWSWIRE) -- HIKMICRO, a leading creator in hunting technology, today presented its groundbreaking "digital system" concept at the IWA Outdoor Classics 2025 show. The company's vision …
SHEIN launches affiliate program for Australia
GlobeNewswire
·
March 20, 2025
SYDNEY, March 20, 2025 (GLOBE NEWSWIRE) -- Global online fashion and lifestyle retailer SHEIN is excited to announce the official launch of its Affiliate Program in Australia, offering content creators, influencers, and digital entrepreneurs an opportunity …
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
GlobeNewswire
·
March 20, 2025
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient market Acquisition advances Paratek’s vision to become a multi-product company focused on …
HUTCHMED Highlights Savolitinib SAVANNAH Phase II and Other Data at European Lung Cancer Congress 2025
GlobeNewswire
·
March 20, 2025
— SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a promising chemo-free oral treatment strategy to address mechanisms of resistance in the advanced setting — — Long …